Doug Schenkel
Stock Analyst at Wolfe Research
(3.53)
# 874
Out of 4,754 analysts
66
Total ratings
48.98%
Success rate
31.64%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $50.93 | +17.81% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $63.27 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $37.09 | +61.77% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $18.11 | +54.61% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $228.05 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $155.38 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.02 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $205.69 | +38.56% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $46.74 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $126.33 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $38.22 | +34.75% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $9.85 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $84.20 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $47.55 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $523.64 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $10.39 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $110.39 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.32 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $15.85 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $40.74 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $143.11 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $371.79 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.57 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.42 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.14 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.98 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.06 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.01 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.74 | +558.14% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $20.78 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $272.64 | -66.99% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.09 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $221.09 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $85.99 | -81.39% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $50.93
Upside: +17.81%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $63.27
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $37.09
Upside: +61.77%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $18.11
Upside: +54.61%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $228.05
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $155.38
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.02
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $205.69
Upside: +38.56%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $46.74
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $126.33
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $38.22
Upside: +34.75%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $9.85
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $84.20
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $47.55
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $523.64
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $10.39
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $110.39
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.32
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $15.85
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $40.74
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $143.11
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $371.79
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.57
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.42
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.14
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.98
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.06
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $6.01
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.74
Upside: +558.14%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $20.78
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $272.64
Upside: -66.99%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $7.09
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $221.09
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $85.99
Upside: -81.39%